Compare $MYGN vs $RCEL | Chartloom

Compare

$MYGN vs $RCEL

Myriad Genetics Inc · AVITA Medical Inc

MYGN

Myriad Genetics Inc

RCEL

AVITA Medical Inc

Compare $MYGN vs $RCEL

Comparing Myriad Genetics Inc and AVITA Medical Inc

MYGNMyriad Genetics Inc

RCELAVITA Medical Inc

MYGNMyriad Genetics Inc

Market cap

$407M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.50x

Rev growth (TTM)

-3.2%

YTD performance

-29.8%

52W performance

-43.6%

FCF yield

-3.5%

RCELAVITA Medical Inc

Market cap

$407M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.05x

Rev growth (TTM)

1.0%

YTD performance

280.7%

52W performance

139.7%

FCF yield

-6.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MYGN

RCEL

Detailed metrics comparison

MYGN

Myriad Genetics Inc

RCEL

AVITA Medical Inc

Market Cap

MYGN$407M

RCEL$407M

Enterprise Value

MYGN$413M

RCEL$444M

Price

MYGN$4.31

RCEL$13.21

P/E Ratio

MYGNN/A

RCELN/A

P/S Ratio

MYGN0.50x

RCEL5.38x

EV/Sales

MYGN0.51x

RCEL5.87x

EV/EBITDA

MYGN49.97x

RCEL0.00x

P/B Ratio

MYGN1.43x

RCEL87.44x

P/FCF Ratio

MYGNN/A

RCELN/A

EV/FCF

MYGN-29.05x

RCEL-17.54x

PEG Ratio

MYGNN/A

RCELN/A

Forward P/E (NTM)

MYGNN/A

RCELN/A

Forward P/S (NTM)

MYGN0.50x

RCEL4.05x

Revenue (TTM)

MYGN$807M

RCEL$76M

Revenue Growth (YoY)

MYGN-3.2%

RCEL1.0%

Forward Rev Growth

MYGN5.6%

RCEL20.3%

Gross Margin (TTM)

MYGN68.8%

RCEL82.1%

Operating Margin (TTM)

MYGN0.0%

RCEL0.0%

EBITDA Margin (TTM)

MYGN-5.0%

RCEL-41.9%

Net Margin (TTM)

MYGN-14.0%

RCEL-57.0%

FCF Margin (TTM)

MYGN-1.8%

RCEL-33.5%

Net Income (TTM)

MYGN$-113M

RCEL$-43M

FCF (TTM)

MYGN$-14M

RCEL$-25M

EPS (TTM)

MYGN-$1.19

RCEL-$1.40

ROE (TTM)

MYGN-3259.0%

RCEL-33790.0%

ROA (TTM)

MYGN-1639.0%

RCEL-7853.0%

ROIC (TTM)

MYGN-2418.0%

RCEL-10295.0%

Cash

MYGN$115M

RCEL$9M

Debt

MYGN$121M

RCEL$47M

Net Cash/Debt

MYGN$-6M

RCEL$-38M

Current Ratio (TTM)

MYGN2.21x

RCEL0.41x

Quick Ratio (TTM)

MYGN1.72x

RCEL0.31x

Debt/Equity (TTM)

MYGN0.40x

RCEL9.39x

Debt/Assets (TTM)

MYGN0.0%

RCEL0.0%

Interest Coverage (TTM)

MYGNN/A

RCELN/A

Net Debt/EBITDA (TTM)

MYGN0.00x

RCEL0.00x

Beta

MYGN1.68

RCEL2.07

52W Performance

MYGN-43.6%

RCEL139.7%

YTD Performance

MYGN-29.8%

RCEL280.7%

% from 52W High

MYGN-49.8%

RCEL-3.7%

% from 52W Low

MYGN57.3%

RCEL310.2%

Asset Turnover (TTM)

MYGN1.17x

RCEL1.38x

FCF Yield (TTM)

MYGN-3.5%

RCEL-6.2%

Earnings Yield (TTM)

MYGN-27.7%

RCEL-10.6%

Dividend Yield (TTM)

MYGNN/A

RCELN/A

Rule of 40

MYGN-4.9

RCEL-32.5

EV/GP/RG

MYGN1.67

RCEL0.22

Ticker research

View MYGN research View RCEL research

Metric	MYGN Myriad Genetics Inc	RCEL AVITA Medical Inc
Market & Valuation
Market Cap	$407M	$407M
Enterprise Value	$413M	$444M
Price	$4.31	$13.21
P/E Ratio	N/A	N/A
P/S Ratio	0.50x	5.38x
EV/Sales	0.51x	5.87x
EV/EBITDA	49.97x	0.00x
P/B Ratio	1.43x	87.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-29.05x	-17.54x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	0.50x	4.05x
Revenue & Growth
Revenue (TTM)	$807M	$76M
Revenue Growth (YoY)	-3.2%	1.0%
Forward Rev Growth	5.6%	20.3%
Profitability
Gross Margin (TTM)	68.8%	82.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-5.0%	-41.9%
Net Margin (TTM)	-14.0%	-57.0%
FCF Margin (TTM)	-1.8%	-33.5%
Net Income (TTM)	$-113M	$-43M
FCF (TTM)	$-14M	$-25M
EPS (TTM)	-$1.19	-$1.40
ROE (TTM)	-3259.0%	-33790.0%
ROA (TTM)	-1639.0%	-7853.0%
ROIC (TTM)	-2418.0%	-10295.0%
Financial Health
Cash	$115M	$9M
Debt	$121M	$47M
Net Cash/Debt	$-6M	$-38M
Current Ratio (TTM)	2.21x	0.41x
Quick Ratio (TTM)	1.72x	0.31x
Debt/Equity (TTM)	0.40x	9.39x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	2.07
52W Performance	-43.6%	139.7%
YTD Performance	-29.8%	280.7%
% from 52W High	-49.8%	-3.7%
% from 52W Low	57.3%	310.2%
Efficiency & Yields
Asset Turnover (TTM)	1.17x	1.38x
FCF Yield (TTM)	-3.5%	-6.2%
Earnings Yield (TTM)	-27.7%	-10.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-4.9	-32.5
EV/GP/RG	1.67	0.22
Ticker research	View MYGN research	View RCEL research

Valuation

P/S Ratio

MYGN

0.50x

RCEL

5.38x

EV/FCF

MYGN

-29.05x

RCEL

-17.54x

Growth & revenue

Revenue Growth TTM

RCEL

1.0%

MYGN

-3.2%

Forward Revenue Growth

RCEL

20.3%

MYGN

5.6%

Profitability & performance

Gross Margin

RCEL

82.1%

MYGN

68.8%

ROE

MYGN

-3259.0%

RCEL

-33790.0%

FCF Yield %

MYGN

-3.5%

RCEL

-6.2%

52-Week Performance

RCEL

139.7%

MYGN

-43.6%

Detailed metrics comparison

MYGN

Myriad Genetics Inc

RCEL

AVITA Medical Inc

Market Cap

MYGN$407M

RCEL$407M

Enterprise Value

MYGN$413M

RCEL$444M

Price

MYGN$4.31

RCEL$13.21

P/E Ratio

MYGNN/A

RCELN/A

P/S Ratio

MYGN0.50x

RCEL5.38x

EV/Sales

MYGN0.51x

RCEL5.87x

EV/EBITDA

MYGN49.97x

RCEL0.00x

P/B Ratio

MYGN1.43x

RCEL87.44x

P/FCF Ratio

MYGNN/A

RCELN/A

EV/FCF

MYGN-29.05x

RCEL-17.54x

PEG Ratio

MYGNN/A

RCELN/A

Forward P/E (NTM)

MYGNN/A

RCELN/A

Forward P/S (NTM)

MYGN0.50x

RCEL4.05x

Revenue (TTM)

MYGN$807M

RCEL$76M

Revenue Growth (YoY)

MYGN-3.2%

RCEL1.0%

Forward Rev Growth

MYGN5.6%

RCEL20.3%

Gross Margin (TTM)

MYGN68.8%

RCEL82.1%

Operating Margin (TTM)

MYGN0.0%

RCEL0.0%

EBITDA Margin (TTM)

MYGN-5.0%

RCEL-41.9%

Net Margin (TTM)

MYGN-14.0%

RCEL-57.0%

FCF Margin (TTM)

MYGN-1.8%

RCEL-33.5%

Net Income (TTM)

MYGN$-113M

RCEL$-43M

FCF (TTM)

MYGN$-14M

RCEL$-25M

EPS (TTM)

MYGN-$1.19

RCEL-$1.40

ROE (TTM)

MYGN-3259.0%

RCEL-33790.0%

ROA (TTM)

MYGN-1639.0%

RCEL-7853.0%

ROIC (TTM)

MYGN-2418.0%

RCEL-10295.0%

Cash

MYGN$115M

RCEL$9M

Debt

MYGN$121M

RCEL$47M

Net Cash/Debt

MYGN$-6M

RCEL$-38M

Current Ratio (TTM)

MYGN2.21x

RCEL0.41x

Quick Ratio (TTM)

MYGN1.72x

RCEL0.31x

Debt/Equity (TTM)

MYGN0.40x

RCEL9.39x

Debt/Assets (TTM)

MYGN0.0%

RCEL0.0%

Interest Coverage (TTM)

MYGNN/A

RCELN/A

Net Debt/EBITDA (TTM)

MYGN0.00x

RCEL0.00x

Beta

MYGN1.68

RCEL2.07

52W Performance

MYGN-43.6%

RCEL139.7%

YTD Performance

MYGN-29.8%

RCEL280.7%

% from 52W High

MYGN-49.8%

RCEL-3.7%

% from 52W Low

MYGN57.3%

RCEL310.2%

Asset Turnover (TTM)

MYGN1.17x

RCEL1.38x

FCF Yield (TTM)

MYGN-3.5%

RCEL-6.2%

Earnings Yield (TTM)

MYGN-27.7%

RCEL-10.6%

Dividend Yield (TTM)

MYGNN/A

RCELN/A

Rule of 40

MYGN-4.9

RCEL-32.5

EV/GP/RG

MYGN1.67

RCEL0.22

Ticker research

View MYGN research View RCEL research

Metric	MYGN Myriad Genetics Inc	RCEL AVITA Medical Inc
Market & Valuation
Market Cap	$407M	$407M
Enterprise Value	$413M	$444M
Price	$4.31	$13.21
P/E Ratio	N/A	N/A
P/S Ratio	0.50x	5.38x
EV/Sales	0.51x	5.87x
EV/EBITDA	49.97x	0.00x
P/B Ratio	1.43x	87.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-29.05x	-17.54x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	0.50x	4.05x
Revenue & Growth
Revenue (TTM)	$807M	$76M
Revenue Growth (YoY)	-3.2%	1.0%
Forward Rev Growth	5.6%	20.3%
Profitability
Gross Margin (TTM)	68.8%	82.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-5.0%	-41.9%
Net Margin (TTM)	-14.0%	-57.0%
FCF Margin (TTM)	-1.8%	-33.5%
Net Income (TTM)	$-113M	$-43M
FCF (TTM)	$-14M	$-25M
EPS (TTM)	-$1.19	-$1.40
ROE (TTM)	-3259.0%	-33790.0%
ROA (TTM)	-1639.0%	-7853.0%
ROIC (TTM)	-2418.0%	-10295.0%
Financial Health
Cash	$115M	$9M
Debt	$121M	$47M
Net Cash/Debt	$-6M	$-38M
Current Ratio (TTM)	2.21x	0.41x
Quick Ratio (TTM)	1.72x	0.31x
Debt/Equity (TTM)	0.40x	9.39x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	2.07
52W Performance	-43.6%	139.7%
YTD Performance	-29.8%	280.7%
% from 52W High	-49.8%	-3.7%
% from 52W Low	57.3%	310.2%
Efficiency & Yields
Asset Turnover (TTM)	1.17x	1.38x
FCF Yield (TTM)	-3.5%	-6.2%
Earnings Yield (TTM)	-27.7%	-10.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-4.9	-32.5
EV/GP/RG	1.67	0.22
Ticker research	View MYGN research	View RCEL research